CD8A and lung cancer: To investigate whether tumors induce alterations in the composition of peripheral blood CD8+ T cells, we retrospectively analyzed CD8+ T cells in the PBMCs of 53 healthy donors and 349 patients with lung cancer (294 patients with NSCLC and 55 patients with SCLC) (Supplementary Table 1).